FDA WARNING_LETTER - Cargill, Inc. - February 27, 2008
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Cargill, Inc.'s medicated feed mill in Billings, Montana, from February 25-27, 2008, revealed significant deviations from cGMP regulations for Medicated Feeds (21 C.F.R. Part 225), rendering manufactured feeds adulterated. Additionally, Llama Mineral feed contained unapproved chlortetracycline, making it unsafe and adulterated.
The firm's March 13, 2008, response to the FDA-483 was deemed insufficient. Key violations include: 1. Failure to investigate and implement corrective actions for out-of-limit medicated feed assays (e.g., sulfamethazine levels 24.4-26% above potency in cattle feed, with 7-10 month delays in investigation), violating 21 C.F.R. 225.58(d). 2. Failure to discontinue distribution of medicated feeds that failed potency assays, violating 21 C.F.R. 225.58(e). 3. Inadequate cleanout procedures, leading to unsafe cross-contamination. Examples include chlortetracycline in Nutrena Naturewise Lamb and Sheep Feed (up to 10 times labeled potency), Nutrabeef Cattle Grower Feed (4.8 ppm), Miller FDLT 45/27 (88.
ID · 375f1237-492f-4493-b78b-54f21d80d1ff
Full citation text and observation details available on the Dashboard.